Abstract
No public abstract is available from the verified source records.
Céleste M. Chevalier, Robin Nijveldt, Raymond J. Kim
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
openalex
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Results of coronary artery surgery in patients with poor left ventricular function (CASS)
10.1161/01.cir.68.4.785 · 1983
2021 ACC/AHA/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines
2022
A standardized definition of ischemic cardiomyopathy for use in clinical research
10.1016/s0735-1097(01)01738-7 · 2002
Arrhythmic and mortality outcomes among ischemic versus nonischemic cardiomyopathy patients receiving primary ICD therapy
10.1016/j.jacep.2021.06.020 · 2022
Effect of carvedilol on survival in severe chronic heart failure
10.1056/nejm200105313442201 · 2001
Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy
10.1056/nejm200004133421502 · 2000
Prognostic value of cardiac magnetic resonance imaging in patients with a working diagnosis of MINOCA-an outcome study with up to 10 years of follow-up
10.1161/circimaging.122.014454 · 2023
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function
10.1161/01.cir.100.19.1992 · 1999
Cardiovascular magnetic resonance assessment of human myocarditis
10.1161/01.cir.0000118493.13323.81 · 2004
The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy
10.1016/j.jacc.2004.03.035 · 2004
Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction
10.1016/s0140-6736(00)03567-4 · 2001
Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement
10.1016/j.jacc.2006.01.059 · 2006
Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation
10.1161/hc2301.092121 · 2001
Acute coronary findings at autopsy in heart failure patients with sudden death
10.1161/01.cir.102.6.611 · 2000
Echocardiographic features of congestive cardiomyopathy compared with normal subjects and patients with coronary artery disease
10.1161/01.cir.49.6.1153 · 1974
Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign
10.1016/s0735-1097(84)80392-7 · 1984
Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy
10.1001/archinte.1992.00400160075014 · 1992
Tl-201 myocardial SPECT in differentiation of ischemic from nonischemic dilated cardiomyopathy in patients with left ventricular dysfunction
10.1016/s1071-3581(03)00456-2 · 2003
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis
10.1016/j.jacc.2003.08.043 · 2004
Feasibility of diagnosing chronic myocarditis by endomyocardial biopsy
10.1007/bf02767044 · 1997
Risk factors for the progression of coronary artery calcification in asymptomatic subjects
10.1161/circulationaha.106.674143 · 2007
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction
10.1056/nejm200011163432003 · 2000
Myocardial viability
2006
Relaxation of water protons in the intra‐ and extracellular regions of blood containing Gd(DTPA)
10.1002/mrm.1910030514 · 1986
Extracellular space and ionic distribution in rat ventricle
10.1152/ajplegacy.1974.227.3.676 · 1974
Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury
10.1161/hc0202.102016 · 2002
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs
10.1161/01.cir.56.5.786 · 1977
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing β-blocker therapy
10.1161/01.cir.0000095029.57483.60 · 2003
Ischemic cardiomyopathy: a clinicopathologic study of fourteen patients
10.1016/0002-8703(80)90663-8 · 1980
Cardiomyopathic syndrome caused by coronary artery disease. III: Prospective clinicopathological study of its prevalence among patients with clinically unexplained chronic heart failure
10.1136/hrt.41.5.613 · 1979
Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients
10.1016/0002-9149(87)90618-7 · 1987
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance
10.1161/01.cir.0000078641.19365.4c · 2003
Recognition of the importance of embolization in atherosclerotic vascular disease
10.1161/01.cir.101.5.570 · 2000
Mechanisms of plaque rupture mechanical and biologic interactions
10.1016/s0008-6363(98)00308-3 · 1999
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy
10.1016/j.jacc.2006.07.049 · 2006
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy
10.1001/jama.2013.1363 · 2013
Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance
10.1016/j.jacc.2004.11.037 · 2005
The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis
10.1016/j.jjcc.2008.03.002 · 2008
Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement
10.1016/j.jcmg.2018.07.015 · 2019
Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study
2020
Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the american heart association
10.1161/cir.0000000000000670 · doi-reference
10.1016/j.ahj.2013.09.012
10.1016/j.ahj.2013.09.012 · doi-reference
Identifying the infarct-related artery in patients with non-ST-segment-elevation myocardial infarction
10.1161/circinterventions.118.007305 · doi-reference
Nonischemic or dual cardiomyopathy in patients with coronary artery disease
10.1161/circulationaha.123.067032 · doi-reference
Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology
10.1161/circulationaha.110.011346 · doi-reference
Intravascular ultrasound analysis of infarct-related and non–infarct-related arteries in patients who presented with an acute myocardial infarction
10.1161/01.cir.0000072768.80031.74 · doi-reference
Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies
10.1093/eurheartj/ehi258 · doi-reference
Detection of myocardial damage in patients with sarcoidosis
10.1161/circulationaha.109.851352 · doi-reference
Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis
10.1093/ehjci/jeu182 · doi-reference
Gadolinium-enhancedmagnetic resonance imagingin hypertrophic cardiomyopathy
10.1016/s0735-1097(03)00190-6 · doi-reference
Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy—an expert consensus document of the European association of cardiovascular imaging
10.1093/ehjci/jew229 · doi-reference
Prognostic value of nonischemic ringlike left ventricular scar in patients with apparently idiopathic nonsustained ventricular arrhythmias
10.1161/circulationaha.120.047640 · doi-reference
Patients with acute myocarditis following mRNA COVID-19 vaccination
10.1001/jamacardio.2021.2828 · doi-reference
Two different clinical presentations and stages of loeffler endocarditis diagnosed by multimodality investigations
10.1016/j.case.2023.09.003 · doi-reference
Comprehensive assessment of endomyocardial fibrosis with cardiac mri: morphology, function, and tissue characterization
10.1148/rg.2020190148 · doi-reference
Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients
10.1161/circimaging.110.950675 · doi-reference
A new typical finding in late gadolinium enhanced images for the diagnosis of endomyocardial fibrosis-the double V sign
10.1186/1532-429x-13-s1-o40 · doi-reference
Myocardial damage assessed by late gadolinium enhancement on cardiovascular magnetic resonance imaging in cancer patients treated with anthracyclines and/or trastuzumab
10.1093/ehjci/jeaa279 · doi-reference
Myocardial damage detected by late gadolinium enhancement cardiac magnetic resonance is uncommon in peripartum cardiomyopathy
10.1161/jaha.117.005472 · doi-reference
Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping
10.1186/s12968-019-0590-z · doi-reference
Peripartum cardiomyopathy: diagnostic and prognostic value of cardiac magnetic resonance in the acute stage
10.3390/diagnostics12020378 · doi-reference
Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging
10.1007/s00330-008-1067-x · doi-reference
Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension
10.1186/1532-429x-14-11 · doi-reference
LGE patterns in pulmonary hypertension do not impact overall mortality
10.1016/j.jcmg.2014.08.014 · doi-reference
Diagnostic accuracy of cardiovascular magnetic resonance imaging of right ventricular morphology and function in the assessment of suspected pulmonary hypertension results from the ASPIRE registry
10.1186/1532-429x-14-40 · doi-reference
Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension
10.1016/j.amjcard.2007.03.094 · doi-reference
Cardiac magnetic resonance reveals signs of subclinical myocardial inflammation in asymptomatic HIV-infected patients
10.1161/circimaging.115.004091 · doi-reference
Association of HIV infection with cardiovascular pathology based on advanced cardiovascular imaging: a systematic review
10.1001/jama.2022.15078 · doi-reference
Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-strauss syndrome
10.1161/circulationaha.107.721738 · doi-reference
Churg–strauss syndrome-associated heart failure and left ventricular thrombosis
10.1002/ehf2.14244 · doi-reference
Cardiac magnetic resonance imaging findings in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a systematic review
10.1002/acr2.70026 · doi-reference
Cardiovascular magnetic resonance imaging detects cardiac involvement in churg-strauss syndrome
10.1016/j.cardfail.2008.07.227 · doi-reference
LGE prevalence and patterns in severe aortic stenosis: when “junctional” means the same
10.1016/j.ijcard.2023.02.034 · doi-reference
Myocardial scar and remodelling predict long-term mortality in severe aortic stenosis beyond 10 years
10.1093/eurheartj/ehae067 · doi-reference
Myocardial scar and mortality in severe aortic stenosis
10.1161/circulationaha.117.032839 · doi-reference
The prognostic role of late gadolinium enhancement in aortic stenosis: a systematic review and meta-analysis
10.1016/j.jcmg.2019.03.029 · doi-reference
Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis
10.1136/hrt.2005.079392 · doi-reference
Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging
10.1038/sj.ki.5000249 · doi-reference
Patterns of late gadolinium enhancement in chronic hemodialysis patients
10.1016/j.jcmg.2008.03.011 · doi-reference
Clinical characteristics and cardiovascular magnetic resonance findings in stress (Takotsubo) cardiomyopathy
10.1001/jama.2011.992 · doi-reference